This is a Validated Antibody Database (VAD) review about human IFNA1, based on 44 published articles (read how Labome selects the articles), using IFNA1 antibody in all methods. It is aimed to help Labome visitors find the most suited IFNA1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
IFNA1 synonym: IFL; IFN; IFN-ALPHA; IFN-alphaD; IFNA13; IFNA@

Invitrogen
mouse monoclonal (3F9)
  • western blot; human; 1:5000; loading ...; fig 3g
Invitrogen IFNA1 antibody (Thermo Fisher, MA5-24415) was used in western blot on human samples at 1:5000 (fig 3g). Aging (Albany NY) (2021) ncbi
mouse monoclonal (AB5)
  • western blot; mouse; 1:3000; loading ...; fig 1g
Invitrogen IFNA1 antibody (Thermo Scientific, Ab-5) was used in western blot on mouse samples at 1:3000 (fig 1g). Cell Death Dis (2018) ncbi
mouse monoclonal (EBI-1)
  • blocking or activating experiments; human; loading ...; fig 5a
Invitrogen IFNA1 antibody (eBiosciences, EBI-1) was used in blocking or activating experiments on human samples (fig 5a). J Virol (2017) ncbi
mouse monoclonal (MMHA-2)
  • immunohistochemistry - paraffin section; human
In order to study the involvement of type I interferons and endothelial cell adhesion molecules in the development of ultraviolet B-induced systemic lupus erythaematosus skin lesions, Invitrogen IFNA1 antibody (Biosource, MMHA-2) was used in immunohistochemistry - paraffin section on human samples . Ann Rheum Dis (2008) ncbi
mouse monoclonal (MMHA-2)
  • flow cytometry; human
In order to report that IFN-alpha inhibits the IL-7R signal transduction pathway, Invitrogen IFNA1 antibody (Biosource, MMHA-2) was used in flow cytometry on human samples . Blood (2006) ncbi
Santa Cruz Biotechnology
mouse monoclonal (5D4)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1b
Santa Cruz Biotechnology IFNA1 antibody (Santa Cruz, sc-80996) was used in immunohistochemistry - paraffin section on human samples (fig 1b). Ann Rheum Dis (2018) ncbi
mouse monoclonal (F-7)
In order to report that USP17 interacts with HDAC2, Santa Cruz Biotechnology IFNA1 antibody (Santa Cruz, F-7) was used . Int J Clin Exp Pathol (2015) ncbi
mouse monoclonal (F-7)
In order to investigate the regulation of HIB, Santa Cruz Biotechnology IFNA1 antibody (Santa Cruz Biotechnology, F-7) was used . Sci Rep (2015) ncbi
mouse monoclonal (F-7)
In order to show that Wss1 is crucial for cell survival upon exposure to formaldehyde and topoisomerase 1-dependent DNA damage, Santa Cruz Biotechnology IFNA1 antibody (Santa Cruz Biotechnology, F-7) was used . Cell (2014) ncbi
mouse monoclonal (F-7)
In order to show that KLF8 and MMP14 signaling promotes human breast cancer invasion and metastasis, Santa Cruz Biotechnology IFNA1 antibody (Santa Cruz Biotechnology, F-7) was used . Oncogene (2014) ncbi
MABTECH
mouse monoclonal (MT1/3/5)
  • ELISA; human; loading ...; fig 1
In order to test if soluble CTLA-4 controls autoantigen-specific immunity in a model of systemic lupus erythematosus, MABTECH IFNA1 antibody (Mabtech, MT1/3/5) was used in ELISA on human samples (fig 1). Arthritis Res Ther (2016) ncbi
mouse monoclonal (MT2/4/6)
  • ELISA; human; loading ...; fig 1
In order to test if soluble CTLA-4 controls autoantigen-specific immunity in a model of systemic lupus erythematosus, MABTECH IFNA1 antibody (Mabtech, MT2/4/6) was used in ELISA on human samples (fig 1). Arthritis Res Ther (2016) ncbi
Miltenyi Biotec
mouse monoclonal (LT27:295)
  • flow cytometry; human; loading ...; fig 1b
Miltenyi Biotec IFNA1 antibody (Miltenyi Biotec, LT27:295) was used in flow cytometry on human samples (fig 1b). Sci Adv (2019) ncbi
mouse monoclonal (LT27:295)
  • flow cytometry; human; fig 2g
In order to map the lineage of human dendritic cells, Miltenyi Biotec IFNA1 antibody (Miltenyi Biotec, LT27:295) was used in flow cytometry on human samples (fig 2g). Science (2017) ncbi
Abcam
rat monoclonal (F18)
  • flow cytometry; mouse; loading ...; fig 1d
Abcam IFNA1 antibody (Abcam, ab7373) was used in flow cytometry on mouse samples (fig 1d). J Clin Invest (2018) ncbi
BD Biosciences
mouse monoclonal (25723.11)
  • flow cytometry; human; 1:100; loading ...; fig 3a, s4a
BD Biosciences IFNA1 antibody (BD Biosciences, 341117) was used in flow cytometry on human samples at 1:100 (fig 3a, s4a). J Immunother Cancer (2022) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; 1:200; loading ...; fig 6c, 6f
BD Biosciences IFNA1 antibody (BD Biosciences, 557844) was used in flow cytometry on human samples at 1:200 (fig 6c, 6f). Nat Commun (2021) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; fig 1c
BD Biosciences IFNA1 antibody (BD Biosciences, 554552) was used in flow cytometry on human samples (fig 1c). Cell Host Microbe (2021) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; mouse; loading ...; fig s2a
BD Biosciences IFNA1 antibody (BD Biosciences, 4S.B3) was used in flow cytometry on mouse samples (fig s2a). J Exp Med (2020) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; 1:50; loading ...; fig 1d
BD Biosciences IFNA1 antibody (BD Biosciences, 4S.B3) was used in flow cytometry on human samples at 1:50 (fig 1d). Gastroenterology (2019) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 2d
BD Biosciences IFNA1 antibody (BD Biosciences, 554552) was used in flow cytometry on human samples (fig 2d). Cell Rep (2018) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig ex8d
BD Biosciences IFNA1 antibody (BD Pharmingen, 4S.B3) was used in flow cytometry on human samples (fig ex8d). Nature (2018) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig s8
BD Biosciences IFNA1 antibody (BD, 4S.B3) was used in flow cytometry on human samples (fig s8). J Clin Invest (2018) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 1e
BD Biosciences IFNA1 antibody (BD Biosciences, 4S.B3) was used in flow cytometry on human samples (fig 1e). J Immunol (2018) ncbi
mouse monoclonal (NIB42)
  • ELISA; human; 1 ug/ml; fig s5o
BD Biosciences IFNA1 antibody (BD, NIB42) was used in ELISA on human samples at 1 ug/ml (fig s5o). J Cell Biol (2018) ncbi
mouse monoclonal (4S.B3)
  • ELISA; human; 1 ug/ml; fig s5o
BD Biosciences IFNA1 antibody (BD, 4S.B3) was used in ELISA on human samples at 1 ug/ml (fig s5o). J Cell Biol (2018) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 1a
  • ELISA; human; loading ...; fig 3a
BD Biosciences IFNA1 antibody (BD, 4S.B3) was used in flow cytometry on human samples (fig 1a) and in ELISA on human samples (fig 3a). J Immunol (2017) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 3d
BD Biosciences IFNA1 antibody (BD, 554552) was used in flow cytometry on human samples (fig 3d). J Clin Invest (2017) ncbi
mouse monoclonal (NIB42)
  • ELISA; human; loading ...; fig 7b
  • ELISA; mouse; loading ...; fig 5a, 6a
BD Biosciences IFNA1 antibody (BD, 551221) was used in ELISA on human samples (fig 7b) and in ELISA on mouse samples (fig 5a, 6a). J Immunol (2017) ncbi
mouse monoclonal (4S.B3)
  • ELISA; human; loading ...; fig 7b
  • ELISA; mouse; loading ...; fig 5a, 6a
BD Biosciences IFNA1 antibody (BD, 554550) was used in ELISA on human samples (fig 7b) and in ELISA on mouse samples (fig 5a, 6a). J Immunol (2017) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; rhesus macaque; loading ...; tbl 1
In order to establish the ability of the herpes simplex virus-1 VC2 vaccine to elicit immune responses in rhesus macaques, BD Biosciences IFNA1 antibody (BD Biosciences, 4S.B3) was used in flow cytometry on rhesus macaque samples (tbl 1). Vaccine (2017) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig s4b
BD Biosciences IFNA1 antibody (BD Biosciences, 4S.B3) was used in flow cytometry on human samples (fig s4b). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (25723.11)
  • flow cytometry; human; 1:10; loading ...; fig 7b
In order to use flow cytometry and barcoded peptide-major histocompatibility complex multimers to screen for T cell specificities, BD Biosciences IFNA1 antibody (BD, 341117) was used in flow cytometry on human samples at 1:10 (fig 7b). Nat Biotechnol (2016) ncbi
mouse monoclonal (NIB42)
  • ELISA; human; loading ...; fig 1
In order to test if soluble CTLA-4 controls autoantigen-specific immunity in a model of systemic lupus erythematosus, BD Biosciences IFNA1 antibody (BD Biosciences, NIB42) was used in ELISA on human samples (fig 1). Arthritis Res Ther (2016) ncbi
mouse monoclonal (4S.B3)
  • ELISA; human; loading ...; fig 1
In order to test if soluble CTLA-4 controls autoantigen-specific immunity in a model of systemic lupus erythematosus, BD Biosciences IFNA1 antibody (BD Biosciences, 4S.B3) was used in ELISA on human samples (fig 1). Arthritis Res Ther (2016) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; fig 1
BD Biosciences IFNA1 antibody (BD Bioscience, 557844) was used in flow cytometry on human samples (fig 1). Oncoimmunology (2016) ncbi
mouse monoclonal (7N4-1)
  • flow cytometry; human; fig 1
In order to study activation of myeloid dendritic cells, regulatory T cells and effector cells in lichen planus, BD Biosciences IFNA1 antibody (BD Biosciences, 7N4-1) was used in flow cytometry on human samples (fig 1). J Transl Med (2016) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; fig s1
In order to develop an HLA-A2-specific chimeric antigen receptor and use it to generate alloantigen-specific human T regulatory cells, BD Biosciences IFNA1 antibody (BD Biosciences, 557844) was used in flow cytometry on human samples (fig s1). J Clin Invest (2016) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; fig 1
In order to investigate the dynamics and characteristics of natural killer cell types in the human ocular mucosal surface in situ during infection with group D human adenoviruses, BD Biosciences IFNA1 antibody (BD Biosciences, 4S.B3) was used in flow cytometry on human samples (fig 1). Mucosal Immunol (2016) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; fig 6
BD Biosciences IFNA1 antibody (BD, 559326) was used in flow cytometry on human samples (fig 6). J Exp Med (2015) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; fig 2
BD Biosciences IFNA1 antibody (BD Biosciences, 554551) was used in flow cytometry on human samples (fig 2). Oncoimmunology (2015) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human
In order to measure the memory CD4(+) T-cell responses to each varicella zoster virus protein at baseline and after zoster vaccination, BD Biosciences IFNA1 antibody (BD, 4S.B3) was used in flow cytometry on human samples . J Infect Dis (2015) ncbi
mouse monoclonal (4S.B3)
  • ELISA; human; fig 1
BD Biosciences IFNA1 antibody (BD Pharmingen, 554550) was used in ELISA on human samples (fig 1). PLoS ONE (2015) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 1a
In order to determine the role of IL-10 produced by T regulatory cells in patients with immune thrombocytopenia, BD Biosciences IFNA1 antibody (BD Bioscience, 557074) was used in flow cytometry on human samples (fig 1a). Immunol Res (2015) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human
BD Biosciences IFNA1 antibody (BD Biosciences, 4S.B3) was used in flow cytometry on human samples . Rheumatology (Oxford) (2015) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; rhesus macaque
In order to examine the effect of HMBPP-deficient Listeria mutant immunization, BD Biosciences IFNA1 antibody (BD Biosciences, 4S.B3) was used in flow cytometry on rhesus macaque samples . J Leukoc Biol (2014) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human
BD Biosciences IFNA1 antibody (BD Pharmingen, 4S.B3) was used in flow cytometry on human samples . Virol J (2014) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 6c
BD Biosciences IFNA1 antibody (BD Bioscience, 4S.B3) was used in flow cytometry on human samples (fig 6c). J Immunol (2014) ncbi
mouse monoclonal (25723.11)
  • flow cytometry; human; loading ...; fig s2
In order to correlate biomarkers associated with coagulation, monocyte activation, and inflammation in elite controllers of HIV infection, BD Biosciences IFNA1 antibody (BD Bioscience, 25723.11) was used in flow cytometry on human samples (fig s2). J Infect Dis (2014) ncbi
Articles Reviewed
  1. Bajor M, Graczyk Jarzynka A, Marhelava K, Burdzińska A, Muchowicz A, Góral A, et al. PD-L1 CAR effector cells induce self-amplifying cytotoxic effects against target cells. J Immunother Cancer. 2022;10: pubmed publisher
  2. Petley E, Koay H, Henderson M, Sek K, Todd K, Keam S, et al. MAIT cells regulate NK cell-mediated tumor immunity. Nat Commun. 2021;12:4746 pubmed publisher
  3. Motozono C, Toyoda M, Zahradník J, Saito A, Nasser H, Tan T, et al. SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity. Cell Host Microbe. 2021;29:1124-1136.e11 pubmed publisher
  4. Xiong Y, Liu D, Shen R, Xiong Y. A short deletion in the DNA-binding domain of STAT3 suppresses growth and progression of colon cancer cells. Aging (Albany NY). 2021;13:5185-5196 pubmed publisher
  5. Okumura G, Iguchi Manaka A, Murata R, Yamashita Kanemaru Y, Shibuya A, Shibuya K. Tumor-derived soluble CD155 inhibits DNAM-1-mediated antitumor activity of natural killer cells. J Exp Med. 2020;217: pubmed publisher
  6. Maarifi G, Smith N, Maillet S, Moncorgé O, Chamontin C, Edouard J, et al. TRIM8 is required for virus-induced IFN response in human plasmacytoid dendritic cells. Sci Adv. 2019;5:eaax3511 pubmed publisher
  7. Karimzadeh H, Kiraithe M, Oberhardt V, Salimi Alizei E, Bockmann J, Schulze zur Wiesch J, et al. Mutations in Hepatitis D Virus Allow It to Escape Detection by CD8+ T Cells and Evolve at the Population Level. Gastroenterology. 2019;156:1820-1833 pubmed publisher
  8. Kim C, Hu B, Jadhav R, Jin J, Zhang H, Cavanagh M, et al. Activation of miR-21-Regulated Pathways in Immune Aging Selects against Signatures Characteristic of Memory T Cells. Cell Rep. 2018;25:2148-2162.e5 pubmed publisher
  9. Song M, Sandoval T, Chae C, Chopra S, Tan C, Rutkowski M, et al. IRE1α-XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activity. Nature. 2018;562:423-428 pubmed publisher
  10. Bi E, Li R, Bover L, Li H, Su P, Ma X, et al. E-cadherin expression on multiple myeloma cells activates tumor-promoting properties in plasmacytoid DCs. J Clin Invest. 2018;128:4821-4831 pubmed publisher
  11. Petrelli A, Mijnheer G, Hoytema van Konijnenburg D, van der Wal M, Giovannone B, Mocholí E, et al. PD-1+CD8+ T cells are clonally expanding effectors in human chronic inflammation. J Clin Invest. 2018;128:4669-4681 pubmed publisher
  12. Walia M, Taylor S, Ho P, Martin T, Walkley C. Tolerance to sustained activation of the cAMP/Creb pathway activity in osteoblastic cells is enabled by loss of p53. Cell Death Dis. 2018;9:844 pubmed publisher
  13. Walwyn Brown K, Guldevall K, Saeed M, Pende D, Önfelt B, MacDonald A, et al. Human NK Cells Lyse Th2-Polarizing Dendritic Cells via NKp30 and DNAM-1. J Immunol. 2018;201:2028-2041 pubmed publisher
  14. Sarkar M, Hile G, Tsoi L, Xing X, Liu J, Liang Y, et al. Photosensitivity and type I IFN responses in cutaneous lupus are driven by epidermal-derived interferon kappa. Ann Rheum Dis. 2018;77:1653-1664 pubmed publisher
  15. Srpan K, Ambrose A, Karampatzakis A, Saeed M, Cartwright A, Guldevall K, et al. Shedding of CD16 disassembles the NK cell immune synapse and boosts serial engagement of target cells. J Cell Biol. 2018;217:3267-3283 pubmed publisher
  16. Salio M, Gasser O, González López C, Martens A, Veerapen N, Gileadi U, et al. Activation of Human Mucosal-Associated Invariant T Cells Induces CD40L-Dependent Maturation of Monocyte-Derived and Primary Dendritic Cells. J Immunol. 2017;199:2631-2638 pubmed publisher
  17. Watanabe R, Shirai T, Namkoong H, Zhang H, Berry G, Wallis B, et al. Pyruvate controls the checkpoint inhibitor PD-L1 and suppresses T cell immunity. J Clin Invest. 2017;127:2725-2738 pubmed publisher
  18. Decalf J, Desdouits M, Rodrigues V, Gobert F, Gentili M, Marques Ladeira S, et al. Sensing of HIV-1 Entry Triggers a Type I Interferon Response in Human Primary Macrophages. J Virol. 2017;91: pubmed publisher
  19. See P, Dutertre C, Chen J, Günther P, McGovern N, Irac S, et al. Mapping the human DC lineage through the integration of high-dimensional techniques. Science. 2017;356: pubmed publisher
  20. Whitfield S, Taylor C, Risdall J, Griffiths G, Jones J, Williamson E, et al. Interference of the T Cell and Antigen-Presenting Cell Costimulatory Pathway Using CTLA4-Ig (Abatacept) Prevents Staphylococcal Enterotoxin B Pathology. J Immunol. 2017;198:3989-3998 pubmed publisher
  21. Stanfield B, Pahar B, Chouljenko V, Veazey R, Kousoulas K. Vaccination of rhesus macaques with the live-attenuated HSV-1 vaccine VC2 stimulates the proliferation of mucosal T cells and germinal center responses resulting in sustained production of highly neutralizing antibodies. Vaccine. 2017;35:536-543 pubmed publisher
  22. Peters C, Häsler R, Wesch D, Kabelitz D. Human Vδ2 T cells are a major source of interleukin-9. Proc Natl Acad Sci U S A. 2016;113:12520-12525 pubmed
  23. Bentzen A, Marquard A, Lyngaa R, Saini S, Ramskov S, Donia M, et al. Large-scale detection of antigen-specific T cells using peptide-MHC-I multimers labeled with DNA barcodes. Nat Biotechnol. 2016;34:1037-1045 pubmed publisher
  24. Dahal L, Basu N, Youssef H, Khanolkar R, Barker R, Erwig L, et al. Immunoregulatory soluble CTLA-4 modifies effector T-cell responses in systemic lupus erythematosus. Arthritis Res Ther. 2016;18:180 pubmed publisher
  25. Peper J, Bösmüller H, Schuster H, Gückel B, Hörzer H, Roehle K, et al. HLA ligandomics identifies histone deacetylase 1 as target for ovarian cancer immunotherapy. Oncoimmunology. 2016;5:e1065369 pubmed publisher
  26. Domingues R, de Carvalho G, Aoki V, da Silva Duarte A, Sato M. Activation of myeloid dendritic cells, effector cells and regulatory T cells in lichen planus. J Transl Med. 2016;14:171 pubmed publisher
  27. Macdonald K, Hoeppli R, Huang Q, Gillies J, Luciani D, Orban P, et al. Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor. J Clin Invest. 2016;126:1413-24 pubmed publisher
  28. Song H, Tao L, Chen C, Pan L, Hao J, Ni Y, et al. USP17-mediated deubiquitination and stabilization of HDAC2 in cigarette smoke extract-induced inflammation. Int J Clin Exp Pathol. 2015;8:10707-15 pubmed
  29. Zhou Z, Xu C, Chen P, Liu C, Pang S, Yao X, et al. Stability of HIB-Cul3 E3 ligase adaptor HIB Is Regulated by Self-degradation and Availability of Its Substrates. Sci Rep. 2015;5:12709 pubmed publisher
  30. Yawata N, Selva K, Liu Y, Tan K, Lee A, Siak J, et al. Dynamic change in natural killer cell type in the human ocular mucosa in situ as means of immune evasion by adenovirus infection. Mucosal Immunol. 2016;9:159-70 pubmed publisher
  31. Boisson B, Laplantine E, Dobbs K, Cobat A, Tarantino N, Hazen M, et al. Human HOIP and LUBAC deficiency underlies autoinflammation, immunodeficiency, amylopectinosis, and lymphangiectasia. J Exp Med. 2015;212:939-51 pubmed publisher
  32. Partlová S, Bouček J, Kloudová K, Lukešová E, Zábrodský M, Grega M, et al. Distinct patterns of intratumoral immune cell infiltrates in patients with HPV-associated compared to non-virally induced head and neck squamous cell carcinoma. Oncoimmunology. 2015;4:e965570 pubmed
  33. Laing K, Russell R, Dong L, Schmid D, Stern M, Magaret A, et al. Zoster Vaccination Increases the Breadth of CD4+ T Cells Responsive to Varicella Zoster Virus. J Infect Dis. 2015;212:1022-31 pubmed publisher
  34. Rodriguez J, Marchicio J, López M, Ziblat A, Elias F, Fló J, et al. PyNTTTTGT and CpG immunostimulatory oligonucleotides: effect on granulocyte/monocyte colony-stimulating factor (GM-CSF) secretion by human CD56+ (NK and NKT) cells. PLoS ONE. 2015;10:e0117484 pubmed publisher
  35. Li F, Ji L, Wang W, Hua F, Zhan Y, Zou S, et al. Insufficient secretion of IL-10 by Tregs compromised its control on over-activated CD4+ T effector cells in newly diagnosed adult immune thrombocytopenia patients. Immunol Res. 2015;61:269-80 pubmed publisher
  36. Jansen D, Hameetman M, van Bergen J, Huizinga T, van der Heijde D, Toes R, et al. IL-17-producing CD4+ T cells are increased in early, active axial spondyloarthritis including patients without imaging abnormalities. Rheumatology (Oxford). 2015;54:728-35 pubmed publisher
  37. Frencher J, Shen H, Yan L, Wilson J, Freitag N, Rizzo A, et al. HMBPP-deficient Listeria mutant immunization alters pulmonary/systemic responses, effector functions, and memory polarization of Vγ2Vδ2 T cells. J Leukoc Biol. 2014;96:957-67 pubmed publisher
  38. Stingele J, Schwarz M, Bloemeke N, Wolf P, Jentsch S. A DNA-dependent protease involved in DNA-protein crosslink repair. Cell. 2014;158:327-338 pubmed publisher
  39. Sueur C, Lupo J, Mas P, Morand P, Boyer V. Difference in cytokine production and cell cycle progression induced by Epstein-Barr virus Lmp1 deletion variants in Kmh2, a Hodgkin lymphoma cell line. Virol J. 2014;11:94 pubmed publisher
  40. Hebel K, Weinert S, Kuropka B, Knolle J, Kosak B, Jorch G, et al. CD4+ T cells from human neonates and infants are poised spontaneously to run a nonclassical IL-4 program. J Immunol. 2014;192:5160-70 pubmed publisher
  41. Krishnan S, Wilson E, Sheikh V, Rupert A, Mendoza D, Yang J, et al. Evidence for innate immune system activation in HIV type 1-infected elite controllers. J Infect Dis. 2014;209:931-9 pubmed publisher
  42. Lu H, Hu L, Yu L, Wang X, Urvalek A, Li T, et al. KLF8 and FAK cooperatively enrich the active MMP14 on the cell surface required for the metastatic progression of breast cancer. Oncogene. 2014;33:2909-17 pubmed publisher
  43. Reefman E, Kuiper H, Limburg P, Kallenberg C, Bijl M. Type I interferons are involved in the development of ultraviolet B-induced inflammatory skin lesions in systemic lupus erythaematosus patients. Ann Rheum Dis. 2008;67:11-18 pubmed
  44. Schmidlin H, Dontje W, Groot F, Ligthart S, Colantonio A, Oud M, et al. Stimulated plasmacytoid dendritic cells impair human T-cell development. Blood. 2006;108:3792-800 pubmed